Shefali Setia Verma, Ph.D.

faculty photo
Assistant Professor of Pathology and Laboratory Medicine
Instructor, Perelman School of Medicine
Department: Pathology and Laboratory Medicine

Contact information
D202, 3700 Hamilton Walk
Philadelphia, PA 19104
Education:
B.Tech (Biotechnology)
Jaipur National University, 2008.
M.S. (Bioinformatics)
New Jersey Institute of Technology, 2011.
PhD (Bioinformatics and Genomics)
Penn State University, 2018.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Abramowitz, Sarah A; Boulier, Kristin; Keat, Karl; Cardone, Katie M; Shivakumar, Manu; DePaolo, John; Judy, Renae; Bermudez, Francisca; Mimouni, Nour; Neylan, Christopher; : Evaluating Performance and Agreement of Coronary Heart Disease Polygenic Risk Scores. JAMA 333(1): 60-70, Jan 2025.

Nicole Wayne, Venkata S. Singamneni, Rasika Venkatesh, Tess Cherlin, Shefali S. Verma, Marie A. Guerraty: Genetic Insights Into Coronary Microvascular Disease. Microcirculation 32(1), January 2025.

VAaron Sykes, Lannawill Caruth, Shefali Setia Verma, Toshinori Hoshi, Carol Deutsch: Disease-associated Kv1.3 variants are energy compromised with impaired nascent chain folding. Biorxiv January 2025.

Glenda Hoffecker, Karl Keat, Lakeisha Mulugeta-Gordon, Marjorie Risman, Shefali S Verma, Mary Deagostino-Kelly, Sony Tuteja: Estimated clinical utility of multi-gene pharmacogenetic testing in a retrospective cohort of gynecology patients. Pharmacogenomics. Epub, 25(14-15): 1-6, Nov 2024.

Leigh A. Humphries, MD,1 Lindsay A. Guare, BS,2 Margaret A. Rush, MD,1 Meridith Pollie, MD,1 Shefali Setia Verma, PhD,2 Suneeta Senapati, MD, MSCE: GENOTYPE-PHENOTYPE ASSOCIATIONS IN ENDOMETRIOSIS AND ADENOMYOSIS: USING WHOLE-EXOME SEQUENCING TO CHARACTERIZE GENETIC BURDEN IN CANDIDATE GENES ASSOCIATED WITH ENDOMETRIOSIS. Fertility and Sterlity Oct 2024.

Tess Cherlin, Stephanie Mohammed, Sasha Ottey, Katherine Sherif, Shefali S. Verma: Understanding Pain in Polycystic Ovary Syndrome: Health Risks and Treatment Effectiveness. Medrxiv and eLife October 2024.

Cherlin, Tess; Mohammed, Stephanie; Ottey, Sasha; Sherif, Katherine; Setia Verma, Shefali; : Evaluating Performance and Agreement of Coronary Heart Disease Polygenic Risk Scores. medrxiv Oct 2024.

Conlon, D. M., Kanakala, S., Cherlin, T., Ko, Y. -A., Vitali, C., Gurunathan, S., Venkatesh, R., Woerner, J., Guare, L. A., Biobank, P. M., Verma, A., Verma, S. S., & Guerraty, M. A.: Genotype-First Approach Identifies an Association between rs28374544/FOG2S657G and Liver Disease through Alterations in mTORC1 Signaling Genes 15(8), Oct 2024.

MA Rush, N Koelper, LA Humphries, S Setia Verma, S Senapati: Pre- and Post-Operative Hormonal Suppression of Endometriosis: Can We Modify the Symptom-Free Interval? Journal of Minimally Invasive Gynecology 31: S135, Oct 2024.

Jee, Yon Ho; Thibord, Florian; Dominguez, Alicia; Sept, Corriene; Boulier, Kristin; Venkateswaran, Vidhya; Ding, Yi; Cherlin, Tess; Verma, Shefali Setia; Faro, Valeria Lo; : Multi-ancestry polygenic risk scores for venous thromboembolism. Human Molecular Genetics 33(18): 1584-1591, June 2024.

back to top
Last updated: 03/18/2025
The Trustees of the University of Pennsylvania